Hyperventilation is an accepted method for activating epileptic activity in the routine recording of the electroencephalogram (EEG). There have been suggestions in the literature that the method of hyperventilation may be an important variable in determining the success of the method and that, in particular, hyperventilation with the mouth closed (thus ensuring that there is a flow of air through the nose that impinges on the cribriform plate) will be more likely to activate epileptic activity. In a blinded trial patients undergoing routine electroencephalography for epilepsy were hyperventilated twice during the recording, once with mouth open, once with mouth closed; there was a balanced order of presentation. Preliminary results suggest that neither method of activation is superior to the other and the overall activation rate of spike wave activity is low.
It may be difficult to clinically distinguish non-epileptic seizures (NES) from epileptic seizures on clinical grounds. Various models have been proposed to explain NES, including the presence of additional psychiatric disturbances, such as depression, anxiety or hysterical conversion disorders. No physiological studies have so far demonstrated a conclusive biological basis for NES. We wish to test the hypothesis that NES may have an abnormal response to novel stimuli compared to a control population.
Fifteen NES patients were compared with 15 healthy controls. MMN was recorded in a passive reading condition to tones. Onset and offset latencies, and amplitude of MMN were measured from the waveform computed as the difference between the response to the deviant stimulus and the response to the frequent stimulus at each electrode site.
The duration of the MMN was significantly shorter for the NES patients compared with controls (P < 0.004). In addition, the amplitude of the MMN (measured as µV/msec) was significantly smaller for patients than controls at all electrode sites (P < 0.014).
These results suggest physiological differences between patients with NES and controls in terms of their response to unattended auditory stimuli. These differences will be discussed in relation to coexisting depression and anxiety states.
Persistent sodium currents in subicular neurons isolated from patients with temporal lobe epilepsy

M. Vreugdenhil & W. J. Wadman
Neuroscience Unit, Physiology Department, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK
Intrinsically burst-firing neurons of the subiculum are involved in the spread and amplification of epileptic activity. The burst firing capability depends on a persistent sodium current. We measured whole-cell sodium currents in pyramidal neurons isolated from the subiculum resected in drug-resistant epileptic patients and in rats. In half of the cells from both patients and rats the contribution of TTX-sensitive persistent sodium current was < 5% of the peak current amplitude at −30 mV. This persistent sodium current activated with normal kinetics but the voltage dependence of activation was 7 mV more hyperpolarised compared to the transient sodium current. The slope parameter of the voltage dependence of steady-state inactivation of the persistent current was increased compared to the transient sodium current.
The voltage dependence and kinetics of the persistent sodium current in cells from patients was not different from that of control rats but its current density and the relative contribution was 4 times larger in drug-resistant epilepsy patients. The persistent sodium current can account for the intrinsic burst firing of half of the sublcular neurons. The extraordinary big persistent sodium current in a subset of subicular cells from patients may contribute to the intractability of seizures in these patients.
A mutation of the doublecortin gene results in epilepsy and learning difficulties
Peter H. Docin, L. Kinton, S. Shorvon, J. Duncan, S. Sisodiya, M. Gardiner & N. Wood
Institute of Neurology, Queen Square, London WC1N 3BG, UK
Mutations in the doublecortin gene (DCX) have recently been identified inpatients suffering from X-linked lissencephaly (XLIS) in males and subcortical laminar heterotopia (SCLH) in females. Affected individuals have epilepsy and mental retardation resulting from these defects in neuronal migration. We describe a 30 year old female who has had seizures (sensory simple partial seizures, temporal complex partial seizures and secondary generalised attacks) since the age of four associated with learning difficulties, EEGs have shown multi-focal epileptiform abnormalities, and MRI revealed frontal and parietal macrogyria/pachygyria and posterior band heterotopia.
PCR primers from the DCX sequence were used to amplify the 7 coding and 3 non-coding exons, and the products sequenced. Analysis of exon 3 revealed a G to C transversion, resulting in the predicted substitution of an alanine with a proline at position 195. The restriction enzyme Mwol was used to confirm the presence of the mutation and demonstrate its absence in a panel of unrelated control individuals.
Our identification of this mutation expands the spectrum of DCX abnormalities associated with epilepsy, and confirms exon 3 of the DCX gene as a major site for mutations. Further studies of the DCX gene will expand our knowledge of the underlying molecular aetiology of cortical malformationss and childhood epilepsy. Sprague-Dawley rats (n = 14) had a catheter inserted into the jugular vein and a microdialysis probe placed into the frontal cortex and the hippocampus. Two days later, rats were injected with VGB (500 or 1000 mg/kg) intraperitoneally. Blood and microdialysate samples were collected at timed intervals of 8 hours. VGB content was determined by HPLC.
VGB blood and extracellular brain concentrations increased linearly and dose-dependently and brain entry was rapid (mean T max 0.7-1.0±0.1). However, VGB max values were significantly higher in the frontal cortex (22.5±3.2 and 113±11.1 µmol/L after 500 and 1000 mg/kg respectively) compared to that of the hippocampus (12.7 ± 1.6 and 51.7 ± 4.9 µmol/L after 500 and 1000 mg/kg respectively). T 1/2 values for extracellular VGB (2.4-3.6 ± 0.3 h) were greater than that of sera (1.1-1.4 ± 0.1 h).
Our results show that VGB rapidly enters the brain and that its elimination in prolonged compared to blood. Furthermore, its extracellular fluid distribution is brain region specific with frontal cortex concentrations being two fold higher than those seen in the hippocampus.
United Kingdom epilepsy twin register
Dr Michael Johnson & Professor Simon Shorvon
Institute of Neurology, Queen Square, London WC1N 3BG, UK Twin studies are a powerful tool for determining the heritability of phenotypic traits. We propose to establish an Epilepsy Twin Register in the United Kingom, the purpose of which is to establish a national resource for the study of epilepsy genetics.
Twin studies in the United Kingdom are hindered by the absence of a national community-based twin register. As a result, UK twin studies rely on either referral from professional colleagues or patient self-referral. Such methods of ascertaining twin pairs are by their nature, biased. However, an examination of quantitative phenotypic traits within twin pairs concordant for a disorder does not suffer from the same problems of ascertainment bias. With regards to epilepsy, an examination of monozygotic and dizygotic twins concordant for epilepsy will permit an examination of the role heritability plays in determining such epilepsy traits as syndrome. AED response and disease severity. Such an understanding will be invaluable in helping to direct future genetic research in epilepsy.
For women of child-bearing years with epilepsy the teratogenic potential of antiepileptic drugs (AEDs) is a major concern. While risks for the older AEDs have been documented, information is lacking about the newer AEDs. Counselling women as to the safest preparation in this situation is therefore difficult. Bearing this in mind we have set up a nationally based prospective register in the United Kingdom to which all pregnancies occuring in women with epilepsy can be reported for follow-up. Since commencing the study approximately 3 years ago over 600 cases have been reported, and follow-up details are available on over half of these. So far we are unable to provide definitive evidence detailing the risks of the AEDs. We would however appear to have established an effective method by which the safety of each of the preparations used might be estimated. We would encourage all those dealing with women with epilepsy to continue to report suitable cases to registers such as our own so that counselling of these women might be able to be done more accurately.
How much risk does a woman with active epilepsy pose to her newborn child in the puerperium? A pilot study
Cathy Fox & Tim Betts
Birmingham University Seizure Clinic, Queen Elizabeth Psychiatric Hospital, Birmingham B15 2QX, UK
Much attention in the literature has recently been paid to women's issues in epilepsy but most of the literature stops in the delivery room or at the first moment of suckling. Although it is commonly supposed that a woman who continues to have active epilepsy during the puerperium will pose a risk to her child, little assessment of how great a risk this is has been carried out. We present an audit of the puerperal experiences of over 200 women counselled before birth in our women's clinic and contrast this with a number of women seen for the first time in the puerperium (and therefore uncounselled). The audit suggests that in counselled women the risk is very low (women with Juvenile Myoclonic Epilepsy may be particularly at risk, as may women with tonic-clonic seizures that occur without warning, plus those with automatisms or who have prolonged post-ictal confusion). Some women with controlled epilepsy prior to conception may lose that control during the puerperium, so even women with well controlled epilepsy should adopt precautions in the puerperium. The only baby to die (or be seriously injured) in the puerperium born to a woman with epilepsy was killed in the mother's first seizure. 
The Welsh Epilepsy Unit, Department of Neurology, University Hospital of Wales, Cardiff, UK
Since November 1997 we have ascertained all women booking into the ante-natal clinic who take medication for epilepsy by close liaison between midwives and epilepsy nurse specialists.
35 women, mean age 27.4 years, were seen over 15 months. 11 (31%) had been referred directly from midwives and 25 (69%) from the epilepsy unit. 10 (29%) were either previously unknown to, or had been previously discharged from the unit.
20 of the women were in their first pregnancy; 4 of the 20 patients on their second or subsequent pregnancies had had previous miscarriages. Only 22 of the 35 patients had received counselling specifically regarding epilepsy and pregnancy prior to this consultation. 12 of the 40 were taking folate (0.4 mg in 3, 5 mg in 10) at the time of assessment but only 8 of these (22.8% of total) had been on folate for more than 4 weeks prior to conception; folate 5 mg was suggested in a further 4.1 patient on lamotrigine had experienced a previous neonatal death. 16 of the pregnancies had run to term at the time of writing; no major malformations occurred among these.
Awareness of the risks of pregnancies in epilepsy is relatively poor as judged by only 25% taking folate prior to conception. Although efforts to prevent problems in pregnancy must begin prior to conception, this model of care centred around nurse liaison ensures that ascertainment of cases of pregnancy and epilepsy on medication is as complete as possible. The prompt recognition and treatment of tonic-clonic status epilepticus (TCSE) are crucial factors in determining the outcome of this common condition with a high mortality and morbidity. The management of TCSE and of premonitory status was assessed by a retrospective case note audit of all patients presenting to a London teaching hospital, before and after the introduction of a new, widely distributed, management protocol to the hospital. The protocol included lorazepam in place of diazepam as first line therapy, and phenobarbitone in place of phenytoin. Thirteen episodes 'pre-' and 14 episodes 'post-' protocol were identified and data collected on patient demographics, treatment details, seizure outcome, complications and cost. Successful seizure outcome, defined as termination with no recurrence within 24 hours, was achieved after first-line benzodiazepine therapy in 7/13 (54%) cases pre-and 13/14 (93%) post-protocol, with fewer complications and lower cost/patient post-protocol. There was also an improvement in other outcome measures. Further work is ongoing to extend the study periods to 18 months each.
Preliminary conclusions: 1) A widely publicised clear management protocol can improve the management of TCSE. 2) In clinical practice lorazepam has advantages over diazepam, as supported by previous clinical trials (Treiman, NEJM 1998: 369 (12); 192-8) 
Gabapentin as initial monotherapy for new onset partial seizures
Tim Betts
Birmingham University Seizure Clinic, Queen Elizabeth Psychiatric Hospital, Birmingham B15 2QZ, UK
Gobapentin is an accepted 'add on' epileptic drug for patients with resistant partial onset seizures. Recent trials have shown that the drug may have a role as a monotherapy agent as it is as effective as a conventional first line AED (Carbamazepine) in this role with a more acceptable side effect profile. In Birmingham University Seizure Clinic patients presenting with new onset partial seizures have been offered Gabapentin as initial therapy for the last year; doses beyond 2400 mgs total daily dose have not been used because of cost.
In this role the drug is effective, with a low side effect profile. Only 1 of the 17 patients treated has not gained control at a dose below 2400 mg total daily dose. No medication withdrawal because of side effects was necessary.
The advantages of Gabapentin as a first line monotherapy drug are its low side effect profile, its lack of interaction with other drugs and its capacity for rapid escalation if needed. Its disadvantages are that it is not broad spectrum so that the clinician has to be certain that it is a partial onset epilepsy that is being treated (not always ascertainable at the onset of seizures) and its higher cost. For many patients, however, its advantages may outweigh its cost disadvantages: this may be particularly so for initial therapy in young women of child bearing potential.
The effectiveness of lamotrigine in the treatment of photosensitive epilepsy
Caroline Burrow, Dr T. Betts & Professor G. Harding
Clinical Neurophysiology Unit, Aston University, Aston Triangle, Birmingham B4 7ET, UK
Photosensitive Epilepsy (PSE) is characterised by reflex seizures in response to exposure to flickering light stimulation. Common environmental triggers are sunlight, fluorescent lighting and the television.
Sodium valproate (Epilim) has been considered the drug of choice, controlling PSE in approximately 80% of patients (Harding and Jeavons, 1994). However it is well known that sodium valproate is a powerful teratogen which should be avoided by women who are or are likely to become pregnant. With increasing evidence that sodium valproate is associated with hyperandrogenism and polycystic ovary syndrome (Isojarvi et al. 1998) coupled with the higher incidence of PSE in females, it is clear that an alternative treatment for PSE is required.
Lamotrigine (Lamictal) appears to be an appropriate substitute for sodium valproate with evidence of efficacy in PSE with acute administration (Binnie et al. 1986 ). This paper reviews cases of the chronic administration of lamotrigine to new onset PSE patients and to PSE patients transferring from sodium valproate. The effect of lamotrigine on PSE was measured by the response to intermittent photic stimulation on the electroencephalogram, results suggest that treatment with lamotrigine is an effective method of controlling PSE. 
A pilot study of the functional cerebral correlates of vagus nerve stimulation inpatients with epilepsy
Academic Department of Psychological Medicine, Royal London Hospital, 3rd Floor Alexandra Wing, Whitechapel Rd, London E1 1BB, UK
Experimental observations indicate that vagus nerve stimulation (VNS) interrupts chemically-induced seizures in animals. In humans with epilepsy approximately 30% of those fitted with a vagal nerve stimulator have reported at least a 50% reduction in seizure frequency. However, the mechanism by which VNS exerts an anticonvulsant effect is unknown.
Seven subjects with epilepsy and an active vagal nerve stimulator in situ for at least six months underwent single photon emission tomography (SPECT) scanning with simultaneous scalp EEG recording. Subjects were studied in two states; during VNS activity and during a control condition in which the VNS was not active. Measures of regional cerebral activity were obtained using SPECT with the tracer 99m Tc-HMPAO.
SPECT measures of cerebral activity were assessed in thalamic and insular regions. A region of interest analysis demonstrated that rapid cycling stimulation (7 seconds on, 12 seconds off) compared to no stimulation, was associated with relatively decreased activity in the left and right medial thalamic regions. No systematic stimulation-related changes were observed on visual or spectral analyses of the EEG data.
The thalamus is known to have a role in the modulation of on-going cortical EEG activity in animals. Our SPECT results support the hypothesis that VNS may exert an antiepileptic effect by altering thalamic activity.
Talking about photosensitive epilepsy: advice for newly diagnosed adolescents
Dr Fiona Fylan & Professor G. F. A. Harding
Clinical Neurophysiology Unit, Aston University, Birmingham B4 7ET, UK
Effective communication between doctor and patient is vital in photosensitive epilepsy, since adherence to medical advice can reduce the incidence of seizures. This paper draws on health-psychology theory to outline how best to inform patients and their families about photosensitive epilepsy. There are five core information points: epilepsy syndromes; medication; strategies for avoiding further seizures; heritability; and prognosis. A basic explanation and EEG demonstration should be provided, with information about the patient's epilepsy syndrome. Informed decisions about medication should be encouraged. Sodium valproate provides effective protection from photosensitive seizures, but its teratogenicity means that women must plan any pregnancies. In general, there are several effective strategies for avoiding photosensitive seizures. These include viewing television only in a well lit room at least 2 metres from the screen, and using a high-frame-rate television. There is a strong genetic factor in photosensitive epilepsy. Laboratory testing of families is therefore approppriate to identify siblings and children of patients who may also be predisposed to photosensitive seizures. Photosensitive epilepsy will remit in 25% of patients during their third decade of life; the remaining 75% will remain photosensitive. With appropriate advice and treatment, however, photosensitive epilepsy can usually be controlled without patients experiencing reduced quality of life.
Survey of the use of ketogenic diet throughout the UK
Gwyneth Magrath
Dietetic Department, Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK With the introduction of internet communications, parental interest has increased in the use of the ketogenic diet for epilepsy. It was, therefore, decided to audit current practice in the use of the ketogenic diet in the UK. All paediatric dietitions who are members of the Paediatric Group of the British Dietetic Association were surveyed by a postal questionnaire. There was a 51% response rate. Twenty two hospitals used the ketogenic diet. 59% used the traditional 4 : 1 (four parts fat: one part carbohydrate, one part protein) ketogenic diet and 41% used the medium chain triglyceride diet (60% MCT fat). 101 patients were being treated on the ketogenic diet. The age of the patients varied from 1 to 11 years. There were wide variations in its application. 66% of hospitals initiated the diet in hospital; 33% at home. Dietary energy administered varied from 60-90 kcal/kg/day, and there was no consistent policy on vitamin and mineral supplementation. Twenty five patients continued to follow the diet after 12 months.
Therefore, the ketogenic diet is being commonly used for the treatment of epilepsy in the UK. Further research work is needed on its nutritional safety and application.
Effects of information on parental knowledge of febrile convulsions
E. Wassmer & M. Hanlon
Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK
The purpose of this study was to study the effects of giving information to parents with febrile convulsive children.
All parents of children with febrile convulsions who are seen at Worcester Royal Infirmary are given information. Fifty parents of children who had had a first febrile convulsion during May 1996 to December 1996 were interviewed by telephone from July to September 1997. The same questions were asked of fifty parents of children who came to a community health clinic and who had not had febrile convulsions.
The design used open questions and covered medical history, general child health knowledge and knowledge of febrile convulsion. The answers were compared using a chi square test. (significant P < 0.05). Possible confounding factors were tested by correlation test.
No difference was found between the two groups in family structure, housing, and general child health knowledge. Information about febrile convulsions was retained by informed parents. Both groups thought the given information was useful and should be written in the child health record book.
Information about febrile convulsions was remembered by parents.
The position of NHS care for people with epilepsy in the UK K. K. Poole
NSE, Chalfont St Peters, Gerrards Cross, Bucks. SL7 ORJ, UK
As part of the biggest Government study into epilepsy NHS care since the war, a systematic literature review was undertaken. This included a trawl through 6 computer databases using the search terms epilepsy & care and epilepsy & services, which yielded over 500 relevant abstracts. Four major epilepsy journals were also hand-searched going back a decade where possible; Epilepsia, Seizure, Journal of Epilepsy and Epilepsy Research yielding 264 papers. The prevailing view of the services via 25 UK community (general practitioner) studies is that the NHS has generally ignored previous Government recommendations. For a condition with a similar prevalence to diabetes, epilepsy clinics and specialist epilepsy nurses analogous to those in diabetes care are far fewer in number although there is evidence that they may improve the continuity of care. The shortfall of neurologists and paediatric neurologists in the UK is historical in nature but the problem needs to be addressed. The patient perspective of services obtained via interviews and postal questionnaires is predominently negative with poor Doctor communication skills and inadequate provision of information being the commonest complaints. We originally developed a behavioural method utilising a conditioned arousal response to an aromatherapy based olfactory stimulus as a countermeasure against oncoming seizures (Betts, T. et al. Seizure 1999 to be published) using an autohypnotic technique to assist the conditioning; the method was helpful in a proportion of patients and some became, and remained, seizure free. Audit of further use of aromatherapy in our clinic suggests that although the aim has continued to be to develop a conditioned response (i.e. a behavoural approach) some patients can develop this response spontaneously without the use of hypnosis and that in many patients we may be looking at a pharmacological response to the aromatherapy oil rather than a behavioural one. In a significant group of patients better seizure control occurs with intermittant massage with the oil only. We also look at why patients do not respond to the technique, and suggest ways of assessing scientifically the therapeutic effect of these oils on people with epilepsy. Our audit does suggest that massage (despite being time consuming and labour intensive) is a necessary part of the treatment process.
Audit of the use of aromatherapy in an epilepsy clinic
Ictal aggression in a female patient with personality disorder
Dr E. Sorour
Reaside Clinic, Birmingham Great Park, Bristol Road South, Rubery, Birmingham B45 9BE, UK This is a case vignette describing a 39 year old female patient who presented with social isolation, mood swings and impulsive verbal and physical aggressive behaviour since childhood. Previous psychiatric and psychological assessments suggested a diagnosis of personality disorder (Antisocial type). Accurate documentation of her aggression using a specially designed incident form, supplemented with Overt Aggression Rating Scale regular monitoring revealed a consistent ictal nature of the agressive behaviour. A history of possible birth injury and detection of a definite long standing lesion within the brain stem supported the diagnosis of ictal aggression. Treatment with Selective Serotonin Re-uptake inhibitors and Carbamazepine controlled the aggressive behaviour and changed the quality of her life. Importance of accurate documentation of aggression and using better quality incident forms are discussed.
